Cargando…
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice
Co-infection with hepatitis B (HBV) and D virus (HDV) is associated with the most severe course of liver disease. Interferon represents the only treatment currently approved. However, knowledge about the impact of interferons on HDV in human hepatocytes is scant. Aim was to assess the effect of pegy...
Autores principales: | Giersch, Katja, Homs, Maria, Volz, Tassilo, Helbig, Martina, Allweiss, Lena, Lohse, Ansgar W., Petersen, Jörg, Buti, Maria, Pollicino, Teresa, Sureau, Camille, Dandri, Maura, Lütgehetmann, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473824/ https://www.ncbi.nlm.nih.gov/pubmed/28623307 http://dx.doi.org/10.1038/s41598-017-03946-9 |
Ejemplares similares
-
In Vivo Models of HDV Infection: Is Humanizing NTCP Enough?
por: Giersch, Katja, et al.
Publicado: (2021) -
High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort
por: Bockmann, Jan-Hendrik, et al.
Publicado: (2020) -
Hepatitis Delta Virus: HDV-HBV Interactions
por: Sureau, Camille
Publicado: (2006) -
Clinical establishment of a laboratory developed quantitative HDV PCR assay on the cobas6800 high-throughput system
por: Pflüger, Lisa Sophie, et al.
Publicado: (2021) -
HBV and HDV: New Treatments on the Horizon
por: Zuccaro, Valentina, et al.
Publicado: (2021)